We are pleased to announce that we have completed the acquisition of a state-of-the-art API Manufacturing facility in Cork, Ireland. This new addition will strengthen our existing capabilities by providing services for API development, scale-up, and commercial supply. Additionally, the Cork facility will allow us to continue to meet the unique needs of our clients and help provide medicines to the patients they serve.
Designed specifically for new and emerging companies such as Kaleido Biosciences, The Quick to Care™ program is an integrated solution that combines drug substance and drug product development, clinical manufacturing, forecasting, demand planning and clinical trial supply execution managed by a single program manager. Learn how Kaleido Biosciences was able to simplify their supply chain to meet their aggressive timeline with the Quick to Care™ program.
Thermo Fisher Scientific’s Pharma Services business delivers the most complete, end-to-end, contract development and manufacturing, viral vector development and manufacturing, logistics services and clinical trial solutions for pharma and biotech companies of all sizes. Learn more about our capabilities and how we can take your discovery from clinical to commercial.
Sanjay Konagurthu, Ph.D.
Sr. Director, PDS Global
Science & Technologies
Chemistry & ConvictionRead Stories About Our People »
Our global network of pharmaceutical development and manufacturing facilities allows Thermo Fisher Scientific the collaboration and reach to ensure your project gets completed quickly and accurately.
10 December, 2019PharmaOutsourcing The international annual partnering meeting is targeted at R&D and CMC professionals, service providers and Investment Managers, and provides an opportunity to meet, network and discuss best practices related to outsourcing in drug development. Pharma Outsourcing will cover contract research and manufacturing in both small molecule and biological APIs, and the event will be covered by the media. Visit our stand and schedule a meeting with our experts!
23 March, 2020DCAT Week 2020 DCAT Week is the premier business development event for companies engaged in pharmaceutical development and manufacturing and related industries. It is organized and hosted by the Drug, Chemical & Associated Technologies Association (DCAT), a not-for-profit, member-supported, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. Held annually in March, DCAT Week ensures that members have a forum for high-level strategic meetings with key decision makers, timely educational programs, and important networking opportunities.